Optellum is making its Virtual Nodule Clinic software with Lung Cancer Prediction AI available through RapidAI’s Rapid Enterprise Platform.
Cleared by the U.S. Food and Drug Administration (FDA), the Virtual Nodule Clinic includes Patient Discovery AI, which searches radiology reports for documented lung nodules and identifies patients for review, along with workflow tools for patient tracking and follow-up, according to the vendor. Lung Cancer Prediction AI analyzes CT images to assess a nodule’s cancer risk.
Health systems can deploy Optellum’s software on their existing RapidAI platform through a single IT deployment, the company said.
